DK3091462T3 - Fremgangsmåder til evaluering af probabilistiske målinger af klinisk resultat ved anvendelse af genomisk profilering - Google Patents
Fremgangsmåder til evaluering af probabilistiske målinger af klinisk resultat ved anvendelse af genomisk profilering Download PDFInfo
- Publication number
- DK3091462T3 DK3091462T3 DK16165150.0T DK16165150T DK3091462T3 DK 3091462 T3 DK3091462 T3 DK 3091462T3 DK 16165150 T DK16165150 T DK 16165150T DK 3091462 T3 DK3091462 T3 DK 3091462T3
- Authority
- DK
- Denmark
- Prior art keywords
- probabilist
- evaluation
- measures
- methods
- clinical results
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B20/10—Ploidy or copy number detection
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
- G16B25/10—Gene or protein expression profiling; Expression-ratio estimation or normalisation
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/70—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for mining of medical data, e.g. analysing previous cases of other patients
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medical Informatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Pathology (AREA)
- Theoretical Computer Science (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Public Health (AREA)
- Bioinformatics & Computational Biology (AREA)
- Evolutionary Biology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Data Mining & Analysis (AREA)
- Immunology (AREA)
- Primary Health Care (AREA)
- Epidemiology (AREA)
- Databases & Information Systems (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US75135305P | 2005-12-14 | 2005-12-14 | |
US86028006P | 2006-11-20 | 2006-11-20 | |
EP06851479A EP1969514A2 (en) | 2005-12-14 | 2006-12-14 | Methods for assessing probabilistic measures of clinical outcome using genomic profiling |
Publications (1)
Publication Number | Publication Date |
---|---|
DK3091462T3 true DK3091462T3 (da) | 2020-08-31 |
Family
ID=38997601
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK16165150.0T DK3091462T3 (da) | 2005-12-14 | 2006-12-14 | Fremgangsmåder til evaluering af probabilistiske målinger af klinisk resultat ved anvendelse af genomisk profilering |
Country Status (7)
Country | Link |
---|---|
US (2) | US8554488B2 (da) |
EP (2) | EP1969514A2 (da) |
AU (1) | AU2006346804B2 (da) |
CA (1) | CA2633339C (da) |
DK (1) | DK3091462T3 (da) |
IL (1) | IL192199A (da) |
WO (1) | WO2008016374A2 (da) |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999023256A1 (en) | 1997-10-30 | 1999-05-14 | Cold Spring Harbor Laboratory | Probe arrays and methods of using probe arrays for distinguishing dna |
GEP20125384B (en) | 2003-05-23 | 2012-01-25 | Cold Spring Harbor Lab | Representations of nucleotide sequences |
CA2633339C (en) | 2005-12-14 | 2019-03-19 | Cold Spring Harbor Laboratory | Methods for assessing probabilistic measures of clinical outcome using genomic profiling |
EP1974056A2 (en) * | 2005-12-14 | 2008-10-01 | Michael H. Wigler | Use of roma for characterizing genomic rearrangements |
US10522240B2 (en) | 2006-05-03 | 2019-12-31 | Population Bio, Inc. | Evaluating genetic disorders |
US7702468B2 (en) | 2006-05-03 | 2010-04-20 | Population Diagnostics, Inc. | Evaluating genetic disorders |
US9677139B2 (en) | 2009-12-11 | 2017-06-13 | Cold Spring Harbor Laboratory | Genetic markers indicative of a cancer patient response to trastuzumab (herceptin) |
WO2011133889A2 (en) | 2010-04-23 | 2011-10-27 | Cold Spring Harbor Laboratory | NOVEL STRUCTURALLY DESIGNED shRNAs |
US20110301862A1 (en) * | 2010-06-04 | 2011-12-08 | Anton Petrov | System for array-based DNA copy number and loss of heterozygosity analyses and reporting |
WO2012018387A2 (en) | 2010-08-02 | 2012-02-09 | Population Diagnotics, Inc. | Compositions and methods for discovery of causative mutations in genetic disorders |
US8725422B2 (en) | 2010-10-13 | 2014-05-13 | Complete Genomics, Inc. | Methods for estimating genome-wide copy number variations |
PL2630263T5 (pl) | 2010-10-22 | 2022-02-28 | Cold Spring Harbor Laboratory | Zliczanie wariantów kwasów nukleinowych w celu uzyskania informacji o liczbie kopii genomowych |
TWI786520B (zh) * | 2010-11-30 | 2022-12-11 | 香港中文大學 | 與癌症有關之基因或分子變異之檢測 |
US20140011694A1 (en) * | 2011-01-11 | 2014-01-09 | Via Genomes, Inc. | Methods, systems, databases, kits and arrays for screening for and predicting the risk of an identifying the presence of tumors and cancers |
US20130079241A1 (en) * | 2011-09-15 | 2013-03-28 | Jianhua Luo | Methods for Diagnosing Prostate Cancer and Predicting Prostate Cancer Relapse |
DK2766483T3 (da) | 2011-10-10 | 2022-04-19 | Hospital For Sick Children | Fremgangsmåder og sammensætninger til screening for og behandling af udviklingsforstyrrelser |
EP2773779B1 (en) | 2011-11-04 | 2020-10-14 | Population Bio, Inc. | Methods and compositions for diagnosing, prognosing, and treating neurological conditions |
CA2858688A1 (en) | 2011-12-08 | 2013-06-13 | Five3 Genomics, Llc | Mdm2-containing double minute chromosomes and methods therefore |
DK2812452T3 (da) | 2012-02-09 | 2020-06-29 | Population Bio Inc | Fremgangsmåder og sammensætninger til screening og behandling af udviklingsforstyrrelser |
EP2844771A4 (en) * | 2012-05-04 | 2015-12-02 | Complete Genomics Inc | METHOD FOR DETERMINING THE ABSOLUTE GENOME-WIDE COPY COUNTER CHANGES OF COMPLEX TUMORS |
EP2895621B1 (en) | 2012-09-14 | 2020-10-21 | Population Bio, Inc. | Methods and compositions for diagnosing, prognosing, and treating neurological conditions |
US10233495B2 (en) | 2012-09-27 | 2019-03-19 | The Hospital For Sick Children | Methods and compositions for screening and treating developmental disorders |
EP2912587A4 (en) * | 2012-10-24 | 2016-12-07 | Complete Genomics Inc | GENOME EXPLORATION SYSTEM FOR TREATING AND PRESENTING NUCLEOTIDE VARIATIONS IN GENOMIC SEQUENCE DATA |
WO2015103057A1 (en) | 2013-12-30 | 2015-07-09 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Fusion genes associated with progressive prostate cancer |
EP3193944B1 (en) | 2014-07-17 | 2021-04-07 | University of Pittsburgh - Of the Commonwealth System of Higher Education | Methods of treating cells containing fusion genes |
US10724096B2 (en) | 2014-09-05 | 2020-07-28 | Population Bio, Inc. | Methods and compositions for inhibiting and treating neurological conditions |
US11094398B2 (en) | 2014-10-10 | 2021-08-17 | Life Technologies Corporation | Methods for calculating corrected amplicon coverages |
US10395759B2 (en) | 2015-05-18 | 2019-08-27 | Regeneron Pharmaceuticals, Inc. | Methods and systems for copy number variant detection |
CA2994848C (en) | 2015-08-07 | 2021-08-10 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Methods for predicting prostate cancer relapse |
GB2555765A (en) | 2016-05-01 | 2018-05-16 | Genome Res Ltd | Method of detecting a mutational signature in a sample |
US20190130997A1 (en) * | 2016-05-01 | 2019-05-02 | Genome Research Limited | Method of characterising a dna sample |
US10240205B2 (en) | 2017-02-03 | 2019-03-26 | Population Bio, Inc. | Methods for assessing risk of developing a viral disease using a genetic test |
ES2935891T3 (es) | 2018-08-08 | 2023-03-13 | Pml Screening Llc | Métodos para evaluar el riesgo de desarrollar leucoencefalopatía multifocal progresiva causada por virus de John Cunningham mediante pruebas genéticas |
GB2577548B (en) * | 2018-09-28 | 2022-10-26 | Siemens Healthcare Gmbh | Method for determining a subject's genetic copy number value |
WO2023122427A1 (en) * | 2021-12-21 | 2023-06-29 | Foundation Medicine, Inc. | Methods and systems for predicting genomic profiling success |
CN117079825B (zh) * | 2023-06-02 | 2024-01-19 | 中国医学科学院阜外医院 | 一种疾病发生概率预测方法及疾病发生概率确定*** |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6277606B1 (en) | 1993-11-09 | 2001-08-21 | Cold Spring Harbor Laboratory | Representational approach to DNA analysis |
US20040197774A1 (en) | 1992-11-12 | 2004-10-07 | Michael Wigler | Representational approach to DNA analysis |
US5436142A (en) | 1992-11-12 | 1995-07-25 | Cold Spring Harbor Laboratory | Methods for producing probes capable of distingushing variant genomic sequences |
US5569753A (en) | 1994-12-20 | 1996-10-29 | Cold Spring Harbor Laboratory | Cancer detection probes |
US6350576B1 (en) | 1994-12-20 | 2002-02-26 | Cold Spring Harbor Laboratory | Cancer detection probes |
US6272479B1 (en) * | 1997-07-21 | 2001-08-07 | Kristin Ann Farry | Method of evolving classifier programs for signal processing and control |
WO1999023256A1 (en) | 1997-10-30 | 1999-05-14 | Cold Spring Harbor Laboratory | Probe arrays and methods of using probe arrays for distinguishing dna |
US6251601B1 (en) * | 1999-02-02 | 2001-06-26 | Vysis, Inc. | Simultaneous measurement of gene expression and genomic abnormalities using nucleic acid microarrays |
US6647341B1 (en) * | 1999-04-09 | 2003-11-11 | Whitehead Institute For Biomedical Research | Methods for classifying samples and ascertaining previously unknown classes |
US6180349B1 (en) * | 1999-05-18 | 2001-01-30 | The Regents Of The University Of California | Quantitative PCR method to enumerate DNA copy number |
AU2001257448A1 (en) | 2000-05-01 | 2001-11-12 | Cold Spring Harbor Laboratory | Use of representations of dna for genetic analysis |
DE10021320A1 (de) | 2000-05-02 | 2001-11-08 | Voith Paper Patent Gmbh | Doppelsiebformer |
US20030082606A1 (en) | 2001-09-04 | 2003-05-01 | Lebo Roger V. | Optimizing genome-wide mutation analysis of chromosomes and genes |
WO2004001016A2 (en) * | 2002-06-25 | 2003-12-31 | The Children's Hospital Of Philadelphia | Methods for detection of genetic alterations associated with cancer |
GEP20125384B (en) | 2003-05-23 | 2012-01-25 | Cold Spring Harbor Lab | Representations of nucleotide sequences |
US7937225B2 (en) * | 2004-09-03 | 2011-05-03 | New York University | Systems, methods and software arrangements for detection of genome copy number variation |
CA2633339C (en) | 2005-12-14 | 2019-03-19 | Cold Spring Harbor Laboratory | Methods for assessing probabilistic measures of clinical outcome using genomic profiling |
EP1974056A2 (en) | 2005-12-14 | 2008-10-01 | Michael H. Wigler | Use of roma for characterizing genomic rearrangements |
US7702468B2 (en) * | 2006-05-03 | 2010-04-20 | Population Diagnostics, Inc. | Evaluating genetic disorders |
-
2006
- 2006-12-14 CA CA2633339A patent/CA2633339C/en active Active
- 2006-12-14 WO PCT/US2006/047913 patent/WO2008016374A2/en active Application Filing
- 2006-12-14 AU AU2006346804A patent/AU2006346804B2/en not_active Ceased
- 2006-12-14 EP EP06851479A patent/EP1969514A2/en not_active Withdrawn
- 2006-12-14 US US11/639,712 patent/US8554488B2/en active Active
- 2006-12-14 DK DK16165150.0T patent/DK3091462T3/da active
- 2006-12-14 EP EP16165150.0A patent/EP3091462B1/en active Active
-
2008
- 2008-06-15 IL IL192199A patent/IL192199A/en active IP Right Grant
-
2013
- 2013-07-16 US US13/943,571 patent/US20140025307A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2008016374A8 (en) | 2008-07-17 |
EP3091462B1 (en) | 2020-06-17 |
EP1969514A2 (en) | 2008-09-17 |
IL192199A0 (en) | 2008-12-29 |
CA2633339A1 (en) | 2008-02-07 |
AU2006346804A1 (en) | 2008-02-07 |
AU2006346804B2 (en) | 2012-10-04 |
EP3091462A1 (en) | 2016-11-09 |
US20100227768A1 (en) | 2010-09-09 |
US20140025307A1 (en) | 2014-01-23 |
WO2008016374A2 (en) | 2008-02-07 |
US8554488B2 (en) | 2013-10-08 |
CA2633339C (en) | 2019-03-19 |
IL192199A (en) | 2015-10-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK3091462T3 (da) | Fremgangsmåder til evaluering af probabilistiske målinger af klinisk resultat ved anvendelse af genomisk profilering | |
DK1879623T3 (da) | Genterapi til rygmarvssygdomme | |
ATE446090T1 (de) | Thiadiazolidinone als gsk3-inhibitoren | |
DK2012940T3 (da) | Hidtil ukendt rengøringsfremgangsmåde | |
DK2050765T3 (da) | Fremgangsmåder til anvendelse ved til mennesker tilpassede antistoffer | |
ATE507227T1 (de) | Kondensierte bicyclische mtor-inhibitoren | |
DE502006006370D1 (de) | Pipette | |
DK1916890T3 (da) | Forbedrede egenskaber for græsendofytter | |
NO20055077D0 (no) | Anordning ved tannborste | |
DK1888294T3 (da) | Fremgangsmåde til hårdlodning af artikler af rustfrit stål | |
BRPI0716125A2 (pt) | anÁlise salivar | |
DK1718967T3 (da) | Metoder til at detektere Lp-PLA2 aktivitet | |
ATE452132T1 (de) | Benzimidazolthiophenverbindungen als plk- inhibitoren | |
DE602006010947D1 (de) | Messwerkzeug | |
NO20050361D0 (no) | Anordning ved gangvei | |
DE602006009980D1 (de) | Biosensor | |
DE602004025215D1 (de) | Tastsonde | |
DE502005000300D1 (de) | Tastkopf | |
DK2367562T3 (da) | Glycanspecifikke analyseværktøjer | |
ITTS20050005A1 (it) | Procedimento di analisi di stringhe di sicurezza criptate | |
FI20050681A0 (fi) | Paikoitusmenetelmä | |
ES1061722Y (es) | Pavimento desmontable | |
DK2103942T5 (da) | Fremgangsmåde til bestemmelse af typen af en inflammatorisk-rheumatisk sygdom i synovialvæske | |
FI20050298A0 (fi) | Menetelmä protrombiiniajan määrittämiseksi | |
ITCH20050007A1 (it) | Nuove tecnologie per analisi di proteoma |